At close: December 13 at 4:00:02 PM EST
After hours: December 13 at 4:51:11 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
193,059.11
152,547.01
119,033.52
92,875.81
37,293.91
Cost of Revenue
19,994.19
18,900.46
18,668.03
17,995.39
8,861.19
Gross Profit
173,064.92
133,646.54
100,365.49
74,880.41
28,432.72
Operating Expense
192,399.38
148,135.82
140,051.68
129,181.49
86,252.18
Operating Income
-19,334.46
-14,489.27
-39,686.19
-54,301.08
-57,819.45
Net Non Operating Interest Income Expense
-2,190.43
-2,596.59
-1,275.95
-3,019.72
-1,667.54
Other Income Expense
--
-325.20
-3,698.20
-3,995.56
-914.86
Pretax Income
-21,524.89
-17,411.06
-44,660.33
-61,316.36
-60,401.85
Tax Provision
660.52
428.00
360.70
7.70
122.50
Net Income Common Stockholders
-25,613.81
-23,702.24
-48,641.91
-61,769.18
-63,362.96
Diluted NI Available to Com Stockholders
-25,613.81
-23,702.24
-48,641.91
-61,769.18
-63,362.96
Basic EPS
-0.64
-0.70
-1.57
-2.29
-4.44
Diluted EPS
-0.64
-0.70
-1.57
-2.29
-4.44
Basic Average Shares
39,828.41
33,905.16
30,976.46
27,007.96
14,275.15
Diluted Average Shares
39,828.41
33,905.16
30,976.46
27,007.96
14,275.15
Total Operating Income as Reported
-19,334.46
-14,489.27
-43,447.78
-54,301.08
-57,819.45
Total Expenses
212,393.57
167,036.28
158,719.71
147,176.89
95,113.36
Net Income from Continuing & Discontinued Operation
-22,507.56
-20,595.99
-45,535.66
-60,897.70
-58,646.94
Normalized Income
-22,507.56
-20,339.09
-42,614.08
-57,980.95
-57,979.09
Net Interest Income
-2,190.43
-2,596.59
-1,275.95
-3,019.72
-1,667.54
EBIT
-19,009.26
-14,489.27
-39,686.19
-54,301.08
-57,819.45
EBITDA
-10,124.11
-7,889.05
-35,915.95
-53,432.32
-57,421.69
Reconciled Cost of Revenue
19,994.19
18,900.46
18,668.03
17,995.39
8,861.19
Reconciled Depreciation
8,885.16
6,600.23
3,770.23
868.76
397.77
Net Income from Continuing Operation Net Minority Interest
-22,507.56
-20,595.99
-45,535.66
-60,897.70
-58,646.94
Total Unusual Items Excluding Goodwill
--
-325.20
-3,698.20
-3,995.56
-914.86
Total Unusual Items
--
-325.20
-3,698.20
-3,995.56
-914.86
Normalized EBITDA
-10,124.11
-7,563.85
-32,217.76
-49,436.77
-56,506.83
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
-68.29
-776.62
-1,078.80
-247.01
12/31/2020 - 1/29/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TALK Talkspace, Inc.
3.2600
-2.10%
AMWL American Well Corporation
9.30
+3.68%
PHR Phreesia, Inc.
24.94
+1.59%
ACCD Accolade, Inc.
3.4900
+0.29%
OPRX OptimizeRx Corporation
4.9900
+1.22%
GDRX GoodRx Holdings, Inc.
4.7100
+0.21%
EUDA EUDA Health Holdings Limited
5.96
-1.50%
CERT Certara, Inc.
11.47
-2.05%
SPOK Spok Holdings, Inc.
16.70
-0.42%
DRIO DarioHealth Corp.
0.7318
-1.40%